Stocks
Teva Pharmaceutical Industries (TEVA) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 1 279 | -2 094 | 4 409 | -874.0 | 4 333 | 2 025 | ||
| Changes by years, y/y, % | -60% | -264% | -311% | -120% | -596% | +6.5% | |||
Teva Pharmaceutical Industries. EBITDA US GAAP, bln rub
Teva Pharmaceutical Industries. EBITDA US GAAP, changes, %
Teva Pharmaceutical Industries. EBITDA US GAAP, sum by quarters, bln rub
Teva Pharmaceutical Industries (TEVA) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | 755.0 | 1 516 | 45.0 | 254.0 | 210.0 | 2 025 | |
| Changes by years, y/y, % | -28% | +45% | -94% | -74% | -80% | |||
| Changes by quarters, q/q, % | -28% | +101% | -97% | +464% | -17% | |||
